Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01319188
What this trial is testing

Ranibizumab and the Risk of Arterial Thromboembolic Events

Who this might be right for
Age-related Macular DegenerationCoronary Artery DiseaseCerebrovascular Disorders
Ural State Medical University 380
Not applicableEnded earlyNCT04468373
What this trial is testing

Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
VisionCare, Inc. 9
Post-approval studies (Phase 4)UnknownNCT03918590
What this trial is testing

Post Intravitreal Injection Topical NSAID vs. Patching

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
The New York Eye & Ear Infirmary 60
Post-approval studies (Phase 4)Study completedNCT02309281
What this trial is testing

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 33
Large-scale testing (Phase 3)UnknownNCT06229665
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 75
Not applicableEnded earlyNCT00709657
What this trial is testing

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Who this might be right for
Macular DegenerationRegional Blood FlowVascular Endothelial Growth Factor
Medical University of Vienna 8
Post-approval studies (Phase 4)Study completedNCT03117634
What this trial is testing

An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Who this might be right for
Age Related Macular DegenerationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 54
Large-scale testing (Phase 3)UnknownNCT00788177
What this trial is testing

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Klinikum Ludwigshafen 10
Very early researchNot Yet RecruitingNCT07728981
What this trial is testing

Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Tianjin Medical University Eye Hospital 49
Large-scale testing (Phase 3)Ended earlyNCT01402544
What this trial is testing

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 20
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Not applicableStudy completedNCT03712670
What this trial is testing

Nutraceutical Support With Omega-3

Who this might be right for
Retinal Disease
Università degli Studi di Brescia 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607561
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
wetAMDAge Related Macular Degeneration
SCAI Therapeutics 50
Not applicableEnded earlyNCT02479386
What this trial is testing

Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 296
Not applicableUnknownNCT05283941
What this trial is testing

Pistachios and Neural Macular Pigment

Who this might be right for
Macular DegenerationRetinal DegenerationRetinal Diseases+1 more
Tufts University 40
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Large-scale testing (Phase 3)Looking for participantsNCT07317934
What this trial is testing

Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Innostellar Biotherapeutics Co.,Ltd 388
Early research (Phase 1)Study completedNCT03835884
What this trial is testing

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Aerie Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT01796964
What this trial is testing

Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 173
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation